Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)
65.26
+1.75 (2.76%)
Feb 3, 2026, 3:00 PM CST
SHA:688621 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 571.41 | 565.56 | 690.93 | 608.93 | 490.25 | 109.31 |
Short-Term Investments | - | 20 | - | - | - | - |
Trading Asset Securities | 135 | 30 | 30 | 13.11 | 157.6 | - |
Cash & Short-Term Investments | 706.41 | 615.56 | 720.93 | 622.04 | 647.85 | 109.31 |
Cash Growth | 1.75% | -14.62% | 15.90% | -3.98% | 492.70% | 42.90% |
Accounts Receivable | 832.89 | 774.96 | 555.83 | 362.73 | 239.2 | 112.78 |
Other Receivables | 9.24 | 10.16 | 11.21 | 16.17 | 12 | 2.37 |
Receivables | 842.12 | 785.12 | 567.04 | 378.9 | 251.21 | 115.15 |
Inventory | 14.1 | 15.05 | 14.41 | 12.54 | 7.84 | 6.29 |
Prepaid Expenses | - | - | - | - | 1.9 | - |
Other Current Assets | 187.47 | 98.76 | 54.76 | 26.48 | 32.99 | 32.13 |
Total Current Assets | 1,750 | 1,514 | 1,357 | 1,040 | 941.79 | 262.87 |
Property, Plant & Equipment | 179.81 | 211.61 | 220.26 | 197.02 | 161.05 | 74.64 |
Long-Term Investments | 56.06 | 115.69 | 100.75 | 94.75 | 40 | - |
Goodwill | 26.06 | 26.06 | 26.06 | 26.06 | 26.06 | 26.06 |
Other Intangible Assets | 4.58 | 5.41 | 5.39 | 4.2 | 3.32 | 4.04 |
Long-Term Deferred Tax Assets | 88.66 | 64.04 | 38.93 | 16.69 | 5.03 | 2.65 |
Long-Term Deferred Charges | 34.96 | 48.28 | 64.19 | 76.25 | 33.41 | 13.16 |
Other Long-Term Assets | 70.7 | 1.73 | 50.31 | 8.78 | 31.99 | 1.43 |
Total Assets | 2,211 | 1,987 | 1,863 | 1,464 | 1,243 | 384.86 |
Accounts Payable | 43.8 | 7.31 | 7.83 | 22.13 | 12.52 | 9.55 |
Accrued Expenses | 22.13 | 77.24 | 88.72 | 37.29 | 27.33 | 22.51 |
Short-Term Debt | 481 | 309.39 | 383.93 | 201.17 | 138.01 | 23.5 |
Current Portion of Long-Term Debt | 41.47 | 19.3 | - | - | - | - |
Current Portion of Leases | - | 24.78 | 22.1 | 22.54 | 18.98 | - |
Current Income Taxes Payable | 34.38 | 6.6 | 24.92 | 16.93 | 11.42 | 2.82 |
Current Unearned Revenue | 339.32 | 321.43 | 220.83 | 205.85 | 199.85 | 128.29 |
Other Current Liabilities | 12.68 | 12.51 | 12.88 | 12.27 | 9.72 | 5.27 |
Total Current Liabilities | 974.78 | 778.56 | 761.21 | 518.19 | 417.83 | 191.94 |
Long-Term Debt | 48 | 67.2 | - | - | - | - |
Long-Term Leases | 17.95 | 35.12 | 40.62 | 33.84 | 49.72 | - |
Long-Term Unearned Revenue | 3.66 | 2.52 | 3.59 | 2.83 | 5.46 | - |
Long-Term Deferred Tax Liabilities | 0.06 | 1.25 | 0.35 | 0.24 | - | - |
Total Liabilities | 1,046 | 884.65 | 805.76 | 555.1 | 473.01 | 191.94 |
Common Stock | 112 | 112 | 112 | 80 | 80 | 60 |
Additional Paid-In Capital | 391.97 | 375.86 | 474.17 | 499.85 | 499.85 | 52.66 |
Retained Earnings | 758.25 | 612.78 | 453.85 | 317.09 | 182.1 | 76.44 |
Total Common Equity | 1,162 | 1,101 | 1,040 | 896.93 | 761.95 | 189.1 |
Minority Interest | 3 | 2.01 | 17.25 | 11.67 | 7.69 | 3.81 |
Shareholders' Equity | 1,165 | 1,103 | 1,057 | 908.6 | 769.64 | 192.92 |
Total Liabilities & Equity | 2,211 | 1,987 | 1,863 | 1,464 | 1,243 | 384.86 |
Total Debt | 588.42 | 455.79 | 446.65 | 257.55 | 206.71 | 23.5 |
Net Cash (Debt) | 117.99 | 159.77 | 274.28 | 364.48 | 441.14 | 85.81 |
Net Cash Growth | -39.27% | -41.75% | -24.75% | -17.38% | 414.12% | 33.05% |
Net Cash Per Share | 1.07 | 1.42 | 2.45 | 3.26 | 4.50 | 1.02 |
Filing Date Shares Outstanding | 109.28 | 112 | 112 | 112 | 112 | 84 |
Total Common Shares Outstanding | 109.28 | 112 | 112 | 112 | 112 | 84 |
Working Capital | 775.33 | 735.93 | 595.93 | 521.77 | 523.96 | 70.94 |
Book Value Per Share | 10.64 | 9.83 | 9.29 | 8.01 | 6.80 | 2.25 |
Tangible Book Value | 1,132 | 1,069 | 1,009 | 866.68 | 732.57 | 159.01 |
Tangible Book Value Per Share | 10.36 | 9.55 | 9.01 | 7.74 | 6.54 | 1.89 |
Machinery | - | 256.34 | 232.62 | 195.9 | 124.14 | 101.1 |
Construction In Progress | - | - | - | - | 3.4 | - |
Order Backlog | - | 3,273 | - | - | - | - |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.